课题基金 / 基金详情

New drug delivery into inner ear ; possibility of the treatment withnano technology

New drug delivery into inner ear ; possibility of the treatment withnano technology
新药物输送至内耳;
批准号:
19791184
负责人:
YAMAUCHI Daisuke
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

YAMAUCHI Daisuke的其他基金

相似基金

相关文献

中文摘要
翻译
考察了纳米颗粒的药物递送至内耳的潜力。Qdot 655分别与辣根过氧化物酶(HRP)、半乳糖凝集素-1(Galectin-1)、L-谷氨酰胺酸(L-GlutaminAcid)和表皮生长因子(EGF)等多肽偶联。将Qdot注入豚鼠耳蜗中阶后,将Qdot与Galectin 1和EGF一起导入Corti器和Reissner膜。纳米粒子有望用于治疗内耳疾病。
英文摘要
Nano particle was examined for the potential of drug delivery to inner ear. Qdot 655 was conjugated respectively with several peptides which are horseradish peroxidase(HRP), Galectin-1, L-Glutamin Acid and epidermal growth factor(EGF). When Qdot was injected into scala media of the cochlea in guinea pig, Qdots with Galectin 1 and EGF were introduced into organ of Corti and Reissner's membrane. Nano particle is expected as treatment for inner ear disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The objective assessment of electrically induced taste sensation using the
  • 批准号:
    23592472
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2011
  • 负责人:
    YAMAUCHI Daisuke
  • 依托单位:
海外基金